放射性特征可以预测接受治疗的直肠癌患者的反应
Diletta Santini1, Ginevra Danti1, Eleonora Bicci1
1Department of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy.
Diagnostics (Basel, Switzerland)
|August 12, 2023
概括
这项研究开发了一种MRI放射性模型,以预测直肠癌对新辅助化学放射治疗 (nCRT) 的反应. 该模型有助于识别那些对治疗反应良好的患者,指导手术决策.
科学领域:
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
- 医疗成像医学成像
背景情况:
- 结直肠癌具有很大的死亡风险,需要个性化治疗策略.
- 精确评估化学辐射疗法反应对于管理局部晚期直肠癌 (LARC) 至关重要.
- 磁共振成像 (MRI) 对于分期和重新分期直肠癌至关重要,指导治疗决策.
研究的目的:
- 开发一种MRI放射性模型,用于预测直肠癌对新辅助化学放射治疗 (nCRT) 的反应.
- 识别与治疗反应相关的成像特征.
- 评估模型在理解治疗有效性的有用性.
主要方法:
- 对38名接受nCRT治疗的LARC患者进行了回顾性评估,并进行了治疗前和后的MRI.
- 使用T2加权成像和明显扩散系数 (ADC) 地图.
- 提取了定量特征,比较了响应者与非响应者,并使用LASSO回归构建了一个预测模型.
主要成果:
- 确定了显著的MRI特征,区分完整/良好响应者与不完整/不良响应者.
- 拉索回归选择了模型开发的关键特征.
- 接收器操作特征 (ROC) 曲线证明了该模型的预测能力.
结论:
- 基于MRI的放射性模型可以有效地预测直肠癌患者对nCRT的反应.
- 这种方法可以帮助区分需要手术的病变和那些可能通过医疗治疗得到解决的病变.
- 早期识别治疗反应可以优化患者管理和手术规划.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.5K
相关概念视频
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
